The Malpractice Time Bomb in Your Ambulance

How ECG Electrode Misplacement Is Becoming the Next Major Liability Frontier for EMS — and What Every Paramedic Needs to Know to Protect Their Patients, Their Career, and Their Agency

You’ve been a paramedic for eight years. You’ve acquired thousands of 12-lead ECGs. You’ve called in dozens of STEMI alerts. You’ve saved lives. And you have never — not once — been asked in a deposition where exactly you placed V1.

That may be about to change.

As prehospital 12-lead ECG has become the standard of care for STEMI identification and cath lab activation across the United States, the legal expectations placed on EMS providers have quietly expanded. You are no longer just transporting patients. You are making diagnostic decisions — decisions about which hospital to go to, whether to activate a cath lab, whether to administer anticoagulants — based on a tracing whose accuracy depends on where you placed 10 stickers on a patient’s chest. And the published evidence now shows, overwhelmingly, that we’re not placing them correctly.

This blog is not about scaring you out of doing your job. It’s about making sure you understand the liability landscape that is forming around prehospital ECG acquisition, so you can protect yourself, your patients, and your agency by demanding the tools and training that meet the legal standard of care.

The 12-Lead ECG Is Now the Standard of Care — and That Changes Everything

The AHA, ACC, and NAEMSP have all released policies recommending that a 12-lead ECG be performed at the point of first medical contact for patients with signs or symptoms consistent with STEMI (StatPearls/NCBI, 2023). The 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes states that an ECG should be acquired and interpreted within 10 minutes of a patient presenting with symptoms suggestive of ACS.

This means prehospital 12-lead ECG acquisition is no longer optional, aspirational, or “nice to have.” It is the standard of care. And in medical malpractice law, the standard of care is the benchmark against which your actions will be measured.

Here is the legal framework that applies to every paramedic in the country:

Duty of care. Paramedics owe a duty of care to every patient they treat. This includes the duty to perform diagnostic procedures — including 12-lead ECG acquisition — competently and in accordance with published guidelines and local protocols.

Breach of duty. A breach occurs when a paramedic fails to meet the standard of care. If published AHA/ACC guidelines require electrode placement in specific anatomical positions, and a paramedic places electrodes incorrectly, that is a potential breach — regardless of intent.

Causation and harm. If electrode misplacement produces a tracing that leads to a missed STEMI (false negative) or an unnecessary cath lab activation (false positive), and the patient suffers harm as a result, the breach of duty is directly linked to patient harm.

KEY LEGAL POINT: In medical malpractice, the standard is not whether the paramedic “tried their best.” It is whether a similarly trained and experienced paramedic would have done the same thing in the same circumstances. When published research shows that 94.2% of paramedics misplace at least one electrode (Gregory et al., 2021), a plaintiff’s attorney could argue either that the standard is widely violated — or that the standard itself requires better tools.

The Evidence That Plaintiffs’ Attorneys Are Starting to Find

The peer-reviewed literature on ECG electrode misplacement has grown substantially in recent years. This research is not hidden in obscure journals — it is published in venues that any malpractice attorney with a Westlaw subscription can find. And the numbers are alarming:

94.2%

of paramedics misplaced at least one precordial electrode. Only 5.8% achieved correct placement of all six. (Gregory et al., British Paramedic Journal, 2021)

41.6%

of EMS and clinical personnel achieved “acceptable” electrode placement, with 34.2% placing three or fewer electrodes acceptably. (Clopton & Hyrkäs, International Journal of Paramedicine, 2024)

<70%

accuracy rate for identifying STEMI on ECG, per published studies — meaning nearly one-third of STEMI interpretations may be incorrect. (PMC, citing multiple studies)

57%

false-positive STEMI activation rate in one large metropolitan EMS system. (Bosson et al., Prehospital Emergency Care, 2015)

$2.4B

estimated annual wrongful death exposure from missed or delayed MI diagnosis nationally (based on published misdiagnosis rates, malpractice win rates, and average indemnity payments). (CBI analysis based on Newman-Toker et al., AHRQ, 2022)

For a plaintiff’s attorney, this is a goldmine. The argument writes itself: “The published evidence shows that the standard tool used by EMS providers to acquire 12-lead ECGs results in electrode misplacement the vast majority of the time. The defendant paramedic used this tool and, consistent with the published error rates, misplaced electrodes that either masked the patient’s STEMI or triggered an unnecessary procedure. Better technology existed and was available. The defendant and their employer chose not to use it.”

⚠ Missed MI is the second most common malpractice claim in emergency medicine settings, accounting for 5% of all EP malpractice claims and up to 20% of EP malpractice dollars paid. (PMC, 2021) While these figures reflect emergency physician claims, the chain of liability extends to EMS when the prehospital ECG is the basis for triage and transport decisions.

Two Scenarios That Should Keep Every EMS Provider Up at Night

Scenario 1: The Missed STEMI

A 54-year-old man presents with jaw pain and diaphoresis. You acquire a 12-lead. V1 and V2 are placed in the 2nd intercostal space instead of the 4th — a common error documented in every electrode placement study. The resulting tracing shows no ST-segment elevation. You transport to a community hospital without PCI capability. Two hours later, a hospital ECG with correct electrode placement reveals an anterior STEMI. The patient undergoes delayed PCI but sustains significant myocardial damage and develops heart failure. He dies six months later.

His family sues. The plaintiff’s expert testifies that correct V1/V2 placement would have revealed the STEMI in the field, enabling direct transport to a PCI center and timely reperfusion. The expert cites Walsh (2018), who demonstrated that high V1/V2 placement can flatten ST-segment elevation and mask anterior ischemia. The expert cites Gregory et al. (2021), showing that the majority of paramedics place these leads too high. The expert concludes that the paramedic’s electrode placement fell below the standard of care, directly causing the delay in diagnosis and the patient’s death.

Scenario 2: The False Activation

A 62-year-old woman presents with atypical chest discomfort. You acquire a 12-lead with V1 and V2 too high. The tracing shows artifact ST-segment elevation. You activate the cath lab. The patient receives anticoagulants en route. At the hospital, the cardiologist determines no STEMI is present — the elevation was positional artifact. However, the patient’s actual condition was an aortic dissection. The anticoagulants administered based on the false STEMI diagnosis worsen the dissection. The patient suffers a catastrophic outcome.

The family’s attorney argues that correct electrode placement would have produced an accurate ECG, preventing the false STEMI activation and the administration of contraindicated medications. The published literature on false-positive STEMI activations from electrode misplacement supports the claim.

Neither of these scenarios requires malice, recklessness, or incompetence. They only require what the evidence says happens routinely: electrodes placed in the wrong positions because the current tool makes it almost impossible to get them right consistently.

Your Agency’s Exposure — and Yours

In most jurisdictions, malpractice claims against EMS providers are filed against the employing agency under the doctrine of respondeat superior (employer liability for employee actions performed within the scope of employment). However, individual paramedics can also be named as defendants, particularly in cases involving allegations of gross negligence or willful deviation from protocol.

EMS agencies face liability on multiple fronts:

• • Failure to provide adequate training. If an agency does not provide formal, guideline-referenced ECG training — and instead relies on “see one, do one” informal instruction — the agency may be liable for failing to equip its providers with the knowledge to meet the standard of care. A JEMS (2025) article noted that “two studies observed that the sources and mechanisms of ECG training and quality control in the studied hospitals were informal and unclear,” and that some trainees reported being “handed a diagram and sent to acquire their first clinical ECG.”
• • Failure to provide adequate equipment. If a technology exists that demonstrably reduces electrode misplacement and improves ECG accuracy, and an agency chooses not to adopt it, a plaintiff’s attorney could argue that the agency failed to provide its providers with tools that meet the evolving standard of care. This is particularly relevant as the evidence base grows and newer technologies receive FDA registration.
• • Failure to maintain quality assurance. Most EMS agencies have no formal competency assessment for ECG acquisition. There is no standardized certification for ECG electrode placement in the United States. Without a QA program that verifies placement accuracy, agencies have no way to demonstrate that their providers meet the standard.
• • Failure to document electrode placement. If prehospital electrodes are routinely removed before hospital arrival and no documentation of electrode positions exists, there is no way to defend the accuracy of the prehospital ECG in litigation. Gregory et al. (2021) recommended that prehospital electrodes be left in situ to allow hospital clinicians to assess placement accuracy. This recommendation is rarely followed.

What You Can Do Right Now to Protect Yourself

This is not a hopeless situation. The liability exposure from electrode misplacement is real, but it is also addressable. Here is what every EMS provider can do today:

1. 1. Follow published AHA/ACC guidelines for electrode placement. Identify landmarks. Count intercostal spaces. Do not guess. The 2007 AHA ECG guidelines (the most recent) and the 2017 SCST guidelines provide clear anatomical standards. Your local protocol should reference these.
2. 2. Put limb leads on the limbs. For a diagnostic 12-lead ECG, the AHA requires limb electrodes below the shoulders and below the inguinal ligaments — on the limbs, not the torso. Mason-Likar torso placement is acceptable for monitoring but not for diagnostic 12-lead acquisition. The difference matters legally.
3. 3. Document your electrode placement. Note in your PCR that you identified landmarks and placed electrodes in AHA-recommended positions. If you deviated (e.g., limb leads on torso due to patient access), document why. Documentation is your legal shield.
4. 4. Leave electrodes in situ when possible. If your protocol allows, leave prehospital electrodes in place so the receiving facility can assess placement and acquire a comparable serial ECG from the same positions.
5. 5. Advocate for better tools. If technology exists that standardizes electrode placement, reduces misplacement, and enables continuous monitoring from field to cath lab, bring it to your medical director’s attention. Your voice matters.
6. 6. Request formal, guideline-based ECG training. If your agency’s ECG training consists of an informal demonstration, ask for a structured program that references published AHA standards. Clopton and Hyrkäs (2024) found that classroom-based training was significantly associated with better electrode placement accuracy.

A Technology That Closes the Liability Gap

C-Booth Innovations developed the EXG™ Wearable ECG Platform specifically to address the systemic electrode misplacement problem that creates both clinical risk and legal exposure for EMS agencies and providers.

The EXG consolidates all precordial electrode positions into a single, anatomically guided, wearable system. A provider aligns the central device using a sternal and nipple-line marker, and all six chest electrodes are placed simultaneously in their correct anatomical positions. No individual landmark identification. No guesswork. No inter-provider variability.

For EMS agencies evaluating legal risk reduction, the EXG provides:

• • Standardized placement that is defensible in litigation — the device was designed to AHA-compliant anatomical standards and places electrodes where they belong by default.
• • Continuous monitoring from field to cath lab — eliminating the serial comparison problem that arises when prehospital electrodes are removed and hospital electrodes are placed in different positions.
• • Deployment under 60 seconds — faster first ECG supports compliance with AHA’s 10-minute FMC-to-ECG recommendation.
• • Expandable to 18-lead — posterior and right-sided detection that few EMS agencies currently acquire due to the time and complexity of additional electrode placement.
• • Radiolucent design — no need to remove for imaging, maintaining continuous monitoring and eliminating another source of electrode repositioning variability.

The EXG is FDA registered, ISO certified, and universally compatible with existing cardiac monitors.

The Legal Landscape Is Shifting. Don’t Get Caught Unprotected.

The prehospital 12-lead ECG has transformed EMS from a transport service into a diagnostic one. That transformation has saved thousands of lives. But it has also placed paramedics at the center of high-stakes clinical decisions that were once made exclusively by physicians. And with that responsibility comes legal accountability.

The published evidence on electrode misplacement is now extensive, well-cited, and accessible to any attorney. The financial exposure from missed MI and false STEMI activations is in the billions. The gap between what guidelines require and what current tools deliver is documented, measured, and growing.

Every ECG you acquire is a potential exhibit in a future legal proceeding. Every electrode you place is a decision that can be scrutinized by an expert witness. And every time you use a tool that the evidence shows fails the vast majority of the time, you are accepting a risk that better technology could eliminate.

You didn’t get into this profession to worry about lawsuits. You got into it to help people. But protecting yourself legally and delivering the best possible patient care are not competing goals. They are the same goal. And achieving it starts with demanding the tools that make accurate ECG acquisition the default — not the exception.

References

1. Gregory P, Kilner T, Lodge S, Paget S. Accuracy of ECG chest electrode placements by paramedics. British Paramedic Journal. 2021;6(1):8–14.
2. Clopton E, Hyrkäs EK. Assessing the Accuracy of ECG Chest Electrode Placement by EMS and Clinical Personnel. International Journal of Paramedicine. 2024;(6):29–47.
3. Walsh B. Misplacing V1 and V2 can have clinical consequences. American Journal of Emergency Medicine. 2018;36(5):865–870.
4. Bosson N, Kaji AH, Niemann JT, et al. The utility of prehospital ECG transmission in a large EMS system. Prehospital Emergency Care. 2015;19(4):496–503.
5. PMC. Three Cases of Emergency Department Medical Malpractice Involving “Consultations.” (AMI: 5% of EP claims, up to 20% of EP malpractice dollars.) PMC8373181.
6. Clopton E. 12-Lead ECGs: Room for Improvement. JEMS. 2025.
7. StatPearls/NCBI. EMS Utilization of Electrocardiogram in the Field. 2023.
8. Quinn GR, et al. Missed Diagnosis of Cardiovascular Disease: Insights from Malpractice Claims. American Journal of Medicine. 2017.
9. Rao S, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025.
10. De Luca G, et al. Time delay to treatment and mortality in primary angioplasty: every minute of delay counts. Circulation. 2004;109:1223–1225.
11. Newman-Toker DE, et al. Diagnostic Errors in the Emergency Department: A Systematic Review. AHRQ. 2022.
12. Rehman A, et al. Precordial ECG Lead Mispositioning: Its Incidence and Estimated Cost to Healthcare. Cureus. 2020;12(7):e9040.
13. Hadjiantoni A, et al. Systematic review of ECG electrode placement. Cardiology and Cardiovascular Medicine. 2021.
14. García-Niebla J, et al. Technical Mistakes during ECG Acquisition. Annals of Noninvasive Electrocardiology. 2009.
15. Naidu SS, et al. SCAI expert consensus update (endorsed by ACC, AHA, and HRS). 2021.
16. Kania M, et al. The effect of precordial lead displacement on ECG morphology. Medical & Biological Engineering & Computing. 2014.
17. Disclaimer: This blog is for educational purposes only and does not constitute legal advice. EMS providers should consult qualified legal counsel for guidance on liability issues specific to their jurisdiction and circumstances.

About C-Booth Innovations

C-Booth Innovations is pioneering precision in cardiac monitoring with the EXG™ Wearable ECG Platform — founded by two emergency room physicians who understood firsthand that the tools EMS providers use to acquire ECGs have not kept pace with the clinical expectations placed upon them. To learn more or schedule a demonstration, visit cboothinnovations.com or call (760) 800-2109.

© 2026 C-Booth Innovations. All rights reserved. | 5835 Avenida Encinas, Suite 118, Carlsbad, CA 92008